An improved synthesis process of bardoxolone lactone derivatives
A synthesis process and derivative technology, applied in the direction of steroids, organic chemistry, etc., can solve the problems of long synthesis route of Bardoxolone lactone derivatives, heavy synthesis and purification workload, unsuitable for industrial production, etc., to reduce synthesis cost , avoid water pollution, repeatable effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] Example 1: Preparation and structural confirmation of the compound shown in Chemical Formula II
[0041] Dissolve OA (500 mg, 1.1 mmol) and mCPBA (377 mg, 2.2 mmol) in 50 mL of anhydrous CH 2 Cl 2 , stirred at room temperature for 5 hours. The reaction solution was mixed with 200ml CH 2 Cl 2 After dilution, the organic layer was washed three times with saturated sodium bicarbonate solution and saturated brine, dried over anhydrous sodium sulfate, filtered, the filtrate was concentrated, and a white solid (440mg, 85%) was obtained by silica gel column chromatography. 1 H-NMR (300MHz, CDCl 3 ,303K,TMS),δ(ppm):3.883(s,1H,C 12 -H),3.20-3.24(m,1H,C 3 -H),2.14(d,1H,C 18 -H),1.305,1.256,1.197,0.987,0.902,0.882,0.779(s,each3H); 13 C-NMR (75MHz, CDCl 3, 303K, TMS), δ (ppm): 179.977 (C 28 ), 90.642 (C 13 ), 78.859 (C 3 ), 76.323 (C 12 ),55.194,51.107,49.731,44.710,44.568,42.053,41.936,39.391,38.896,36.951,34.142,33.965,33.270,31.563,30.629,29.685,28.769,27.991,27.4...
Embodiment 2
[0042] Embodiment 2: Preparation and structure confirmation of the compound shown in chemical formula III
[0043] The compound represented by chemical formula II (450 mg, 1 mmol) and IBX (1.4 g, 5 mmol) were dissolved in 15 ml of anhydrous DMSO, heated to 105° C., and stirred for 6 hours. Cool to room temperature, terminate the reaction with 100ml of water, and extract 3 times with 100ml of ethyl acetate respectively. The organic layers were combined, washed with saturated sodium bicarbonate solution and saturated brine, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated. The crude product was subjected to silica gel column chromatography to obtain a white solid (364 mg, 81%). 1 H-NMR (300MHz, CDCl 3 ,303K,TMS):,δ7.31,7.28,7.26(t,1H,C 1 -H),6.23(s,1H,C 11 -H),5.95,5.92(d,1H,C 2 -H),2.97,2.93(d,1H,C 18 -H),1.51,1.48,1.19,1.12,1.01,0.95(s,each 3H),0.95(s,6H); 13 C-NMR (75MHz, CDCl 3 ,303K,TMS),δ(ppm):202.61(C 3 ), 191.15 (C 12 ), 177.85 ...
Embodiment 3
[0044] Embodiment 3: Preparation and structural confirmation of the compound shown in chemical formula IV
[0045] The compound represented by chemical formula III (1.0 g, 2.2 mmol), simple iodine (1.7 g, 6.7 mmol) and pyridine (0.7 g, 8.6 mmol) were dissolved in 30 ml THF, and stirred at reflux for 24 hours. The solvent was distilled off from the reaction solution under reduced pressure, the black residue was dissolved in 50ml of ethyl acetate, the organic layer was washed with 10% sodium bicarbonate solution, 5% HCl solution and saturated brine respectively, dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated The amber crude product was obtained, and a white solid (0.97 g, 76%) was obtained by silica gel column chromatography with dichloromethane / petroleum ether=1:1. 1 H-NMR (300MHz, CDCl3, 303K, TMS): δ8.09(s, 1H, C1-H), 6.23(s, 1H, C11-H), 2.99, 2.95(d, 1H, C18-H), 1.51,1.50,1.24,1.19,1.04(s,each 3H),0.97(s,6H); 13C-NMR(75MHz,CDCl3,303K,TMS)...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



